65 i b, drugs, pharmaceuticals, & hematology related products, FSS contract award
Active Awarded Last action
- Contract number
- 36F79723D0158
- Awardee
-
Napo Pharmaceuticals Inc. UEI GNMTLLK5JQE5 Part of Jaguar Health, Inc.
- Awarding agency
-
Veterans Integrated Service Network 12
Veterans Health Administration, Department of Veterans Affairs
- Task orders
- 4
Award facts
- Opportunity
-
- M5-Q50A-03-R8: 65IB Drugs, Pharmaceuticals & Hematology Related Products Solicitation Refreshment Pre-Solicitation · M5Q50A03R8 · Posted Jun 21, 2018
- Last date to order 64% complete
- IDV ceiling
- $1,151,660.00
- Award type
- Multiple award
- Who can order
- All agencies
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Fixed Price with Economic Price Adjustment
Award details come from SAM.gov/FPDS.
About this IDV
GSA awarded a Federal Supply Schedule contract to Napo Pharmaceuticals Inc. under the Pharmaceuticals and Drugs schedule (FSS-61-IB), Schedule 65 IB for drugs, pharmaceuticals, and hematology-related products, on August 1, 2023, with a ceiling value of $1,151,660 and performance through July 31, 2028.
This is a multiple-award indefinite delivery vehicle enabling VA healthcare facilities nationwide to order against pre-established pricing. Napo Pharmaceuticals, a subsidiary of Jaguar Health Inc., specializes in Mytesi (crofelemer), a 125-milligram oral tablet for treating non-infectious diarrhea in adult HIV/AIDS patients receiving antiretroviral therapy. Place of performance is San Francisco, California.
Four delivery orders have been issued under this schedule contract since award. Veterans Integrated Service Network 20 placed orders valued at $42,225.25 (March 7, 2024; completion March 18, 2024), $3,378.02 (June 3, 2024; completion July 30, 2024), $42,225.25 (October 1, 2024; completion September 30, 2025), and $76,129.68 (October 1, 2025; completion September 30, 2026). All orders are firm fixed-price, open market procurements with no set-aside designation. Each delivery order specifies Mytesi supply to support VA pharmaceutical distribution to veteran patients.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Pharm - mytesi | Veterans Integrated Service Network 20 (VHA) | $77,209 | |
| Mytesi | Veterans Integrated Service Network 20 (VHA) | $42,225 | |
| Mytesi oral tabs | Veterans Integrated Service Network 20 (VHA) | $3,378 | |
| Mytesi | Veterans Integrated Service Network 20 (VHA) | $42,225 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36F79723D0158?
36F79723D0158 was awarded to Napo Pharmaceuticals Inc. by Veterans Integrated Service Network 12 (Veterans Health Administration) on August 1, 2023.
How much is contract 36F79723D0158 worth?
36F79723D0158's own ceiling is $1,151,660.
How many orders have been placed under contract 36F79723D0158?
4 orders have been placed under 36F79723D0158, the latest on October 1, 2025.
Who can order from contract 36F79723D0158?
36F79723D0158 is a multiple award federal supply schedule. All agencies can place orders on it.
Is contract 36F79723D0158 part of a contract vehicle?
Yes. 36F79723D0158 is part of Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36F79723D0158 competed?
The extent of competition for 36F79723D0158 was full and open competition.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV